Company name: Steep Hill Israel
Description: Provider of cannabis genetic research and development services. The company’s cannabis genetic research and development will empower growers with the technology to breed specific strains, based on genetics and expected chemical profiles for specific patient conditions/diseases.
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Region: Middle East
Start up capital raised (USD Million):
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was formed as a joint venture between iCAN and Steep Hill Labs on March 21, 2017.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: